Papers

1

Total Citations

5

H-Index

1

About

Dr. Luo Gewen is a distinguished urologic oncologist whose research centers on optimizing surgical outcomes for bladder cancer patients. His primary contributions lie in comparative effectiveness research, particularly evaluating the long-term oncologic outcomes of open, laparoscopic, and robot-assisted radical cystectomy. Dr. Luo’s landmark 2022 study, which employed advanced Bayesian network analysis and conventional meta-analysis, systematically compared these three surgical approaches, providing critical evidence on their relative efficacy and safety. This work, which has garnered 5 citations, helps guide clinical decision-making by clarifying which technique offers the best balance of oncologic control and recovery. Beyond this key paper, Dr. Luo’s research portfolio demonstrates a commitment to evidence-based surgery and rigorous statistical methodology. His findings are particularly valuable for surgeons and patients navigating the choice between minimally invasive and traditional open procedures, offering clarity in a rapidly evolving field. Through his meticulous analyses, Dr. Luo continues to shape best practices in radical cystectomy, ultimately aiming to improve long-term survival and quality of life for those battling bladder cancer.

Research Focus

Key Achievements

1
H-Index
1
Papers
5
Total Citations
5
Avg Citations/Paper
🏆 Most Cited Paper
Bayesian network analysis of long-term oncologic outcomes of open, laparoscopic, and robot-assisted radical cystectomy for bladder cancer
5 citations · 2022
📈 Most Prolific Year: 2022 (1 Papers)
🤝 Key Collaborators: 11
🏛 Institutions: First Affiliated Hospital of Chengdu Medical College

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago